• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Mylan launches MyHep All in India pharmaasia
    August 18, 2017
    Mylan Pharmaceuticals Private Limited (a subsidiary of Mylan N.V.) has announced the launch of Velpatasvir 100 mg/Sofosbuvir 400mg tablets under the brand name MyHep All in India.
  • Mylan launches MyHep All in India expressbpd
    July 31, 2017
    MyHep All is a fixed-dose combination of Velpatasvir 100 mg/ Sofosbuvir 400 mg tablets

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service